Ocumetics Technology is trading 5.1% down now at CA$0.47 as healthcare stocks weaken broadly, with the XLV sector ETF down 2.19%.
- Broader markets are also lower amid surging oil prices, geopolitical tensions, and defensive positioning ahead of upcoming inflation and central-bank decisions.
- On September 8, the company announced Group Two patient recruitment had begun in Mexico City, targeting Fall 2026 surgeries.
- The update disclosed no negative development or stock-price explanation.